Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. This brief summarizes the main findings of the longer research publication, HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues.
Corporate author(s): PATH, International AIDS Vaccine Initiative
Published: December 2007
Region: Global
Available materials
Making Cervical Cancer Vaccines Widely Available in Developing Countries: Cost and Financing Issues
(Located at www.rho.org)
Hard copies are not available.
English
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
See also:
- > Vaccines and immunization > Human papillomavirus (HPV)
- > Reproductive health > Cervical cancer prevention
For more information…
Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH Publications, 1455 NW Leary Way, Seattle WA 98107